Guidance for industry : CGMP for phase 1 investigational drugs.

Bibliographic Details
Corporate Authors:	Center for Drug Evaluation and Research (U.S.), Center for Biologics Evaluation and Research (U.S.), United States. Food and Drug Administration. Office of Regulatory Affairs
Format:	Government Document eBook
Language:	English
Published:	Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research : Office of Regulatory Affairs, [2008]
Subjects:	Drugs > Testing.
Online Access:	https://purl.fdlp.gov/GPO/LPS111655

Available Online